People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Taris Biomedical Inc | — | Biotechnology | Series B | $36.9M | $535.8M | 2011 |
Sarma Duddy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sarma Duddy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Kevin Bitterman | 1 | 15 |
| Michael Greeley | 1 | 15 |
| Robert Crane | 1 | 7 |
| Diane Marcou | 1 | 5 |
| Michael Cima | 1 | 4 |
| Cary Pfeffer | 1 | 4 |
| Dennis Ausiello | 1 | 4 |
| Christine Bunt | 1 | 4 |
| Ed Kania | 1 | 3 |
| Purnanand Sarma | 1 | 3 |
| Edward Kania | 1 | 2 |
| Ernie Mario | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.